Skip to content

Sign in Start free

Create your free account

Loading your page…

We care for the people who care.

No ads. No selling of your data. No third-party trackers.

Apps

Prognia
Ward
Suture
Osler

Library

Guidelines
Medicines
Articles
Calculators
Explore decks
Blog

Prognia

About
Pricing
Contact

Support us

Founders Wall

© 2026 Prognia · Amsterdam, the NetherlandsPrivacy TermsExchangeRate-API

Medicines · US (FDA)

FDA 2010

FDA

Lamictal XR

Approved 29 Jan 2010OralTablet, extended release

The FDA lists this product in 10 strengths and forms.

Official labelAsk Osler about it

On this page

Composition
Strengths and forms
Official product information

The table holds no label text for this product yet, only the facts beside it. The official product information has the full text.

Composition

Active ingredients: LAMOTRIGINE 100MG

Strengths and forms

The FDA lists each strength of a product separately; these pages share one label.

LAMOTRIGINE 100MG · Tablet, extended releaseThis page
LAMOTRIGINE 25MG · Tablet, extended releaseNDA022509-001 · Prescription
LAMOTRIGINE 200MG · Tablet, extended releaseNDA022509-004 · Prescription
LAMOTRIGINE 50MG · Tablet, extended releaseNDA022509-002 · Prescription
LAMOTRIGINE 300MG · Tablet, extended releaseNDA022115-005 · Prescription
LAMOTRIGINE 100MG · Tablet, extended releaseNDA022115-003 · Prescription
LAMOTRIGINE 25MG · Tablet, extended releaseNDA022115-001 · Prescription
LAMOTRIGINE 250MG · Tablet, extended releaseNDA022115-006 · Prescription
LAMOTRIGINE 200MG · Tablet, extended releaseNDA022115-004 · Prescription
LAMOTRIGINE 50MG · Tablet, extended releaseNDA022115-002 · Prescription

Official product information

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Drugs@FDA lists the approved labels, letters and reviews for application NDA022509.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Brand name: Lamictal XR
Active substance: lamotrigine
Route: Oral
Dosage form: Tablet, extended release
Applicant: Smithkline Beecham
Status: Prescription
FDA approval: 29 Jan 2010
Application: NDA022509-003